Literature DB >> 8769429

Early detachment of colon carcinoma cells during CD95(APO-1/Fas)-mediated apoptosis. I. De-adhesion from hyaluronate by shedding of CD44.

A R Günthert1, J Sträter, U von Reyher, C Henne, S Joos, K Koretz, G Moldenhauer, P H Krammer, P Möller.   

Abstract

Ligation of CD95 (APO-1/Fas) cell surface receptors induces death in apoptosis-sensitive cells. Induction of apoptosis in adherent gamma interferon-stimulated HT-29 and COLO 205 colon carcinoma cells by cross-linking CD95 with anti-APO-1 monoclonal antibody resulted in detachment of the cells from hyaluronate starting about 1 h after antibody exposure. Loss of adhesion was paralleled by a substantial reduction of the multifunctional cell surface adhesion molecule CD44. As evidenced by cycloheximide treatment, this effect was not caused by impaired protein synthesis. Depletion of surface CD44 was also not due to membrane blebbing, since cytochalasin B failed to inhibit ascension from hyaluronate. Instead, ELISA and time kinetics showed increasing amounts of soluble CD44 in the supernatant of CD95-triggered cells. SDS-PAGE revealed that soluble CD44 had an apparent molecular mass of about 20 kD less than CD44 immunoprecipitated from intact cells. Thus, CD95-triggering induced shedding of CD44. Shedding is a novel mechanism operative in early steps of CD95-mediated apoptosis. Shedding surface molecules like CD44 might contribute to the active disintegration of dying epithelial cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8769429      PMCID: PMC2120951          DOI: 10.1083/jcb.134.4.1089

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  41 in total

1.  Monoclonal antibody-mediated tumor regression by induction of apoptosis.

Authors:  B C Trauth; C Klas; A M Peters; S Matzku; P Möller; W Falk; K M Debatin; P H Krammer
Journal:  Science       Date:  1989-07-21       Impact factor: 47.728

2.  A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family.

Authors:  I Stamenkovic; M Amiot; J M Pesando; B Seed
Journal:  Cell       Date:  1989-03-24       Impact factor: 41.582

3.  A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins.

Authors:  L A Goldstein; D F Zhou; L J Picker; C N Minty; R F Bargatze; J F Ding; E C Butcher
Journal:  Cell       Date:  1989-03-24       Impact factor: 41.582

4.  Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance.

Authors:  J Searle; J F Kerr; C J Bishop
Journal:  Pathol Annu       Date:  1982

5.  Dual role of the CD44 molecule in T cell adhesion and activation.

Authors:  Y Shimizu; G A Van Seventer; R Siraganian; L Wahl; S Shaw
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

6.  Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man.

Authors:  S Jalkanen; M Jalkanen; R Bargatze; M Tammi; E C Butcher
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

7.  In situ detection of enterocytic apoptosis in normal colonic mucosa and in familial adenomatous polyposis.

Authors:  J Sträter; K Koretz; A R Günthert; P Möller
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

8.  The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells.

Authors:  I Stamenkovic; A Aruffo; M Amiot; B Seed
Journal:  EMBO J       Date:  1991-02       Impact factor: 11.598

9.  Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons.

Authors:  T A Brown; T Bouchard; T St John; E Wayner; W G Carter
Journal:  J Cell Biol       Date:  1991-04       Impact factor: 10.539

10.  A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.

Authors:  S Yonehara; A Ishii; M Yonehara
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more
  11 in total

1.  Epidermal growth factor-regulated activation of Rac GTPase enhances CD44 cleavage by metalloproteinase disintegrin ADAM10.

Authors:  Toshiyuki Murai; Takayuki Miyauchi; Toshio Yanagida; Yasushi Sako
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

2.  Clinical significance of pAKT and CD44v6 overexpression with breast cancer.

Authors:  Pei Yu; Ling Zhou; Weifeng Ke; Ke Li
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-16       Impact factor: 4.553

3.  Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas.

Authors:  S Schölzel; W Zimmermann; G Schwarzkopf; F Grunert; B Rogaczewski; J Thompson
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

4.  A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth.

Authors:  L Sherman; D Wainwright; H Ponta; P Herrlich
Journal:  Genes Dev       Date:  1998-04-01       Impact factor: 11.361

5.  Epitope-specific antibody-induced cleavage of angiotensin-converting enzyme from the cell surface.

Authors:  Irina V Balyasnikova; Eric H Karran; Ronald F Albrecht; Sergei M Danilov
Journal:  Biochem J       Date:  2002-03-15       Impact factor: 3.857

6.  New isolation technique to study apoptosis in human intestinal epithelial cells.

Authors:  J Grossmann; J M Maxson; C M Whitacre; D E Orosz; N A Berger; C Fiocchi; A D Levine
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

7.  CD44 enhances neuregulin signaling by Schwann cells.

Authors:  L S Sherman; T A Rizvi; S Karyala; N Ratner
Journal:  J Cell Biol       Date:  2000-09-04       Impact factor: 10.539

8.  Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7).

Authors:  B M Wittig; B Johansson; M Zöller; C Schwärzler; U Günthert
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307

9.  Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non-small-cell lung cancer.

Authors:  Kohei Otsubo; Kaname Nosaki; Chiyo K Imamura; Hiroaki Ogata; Akitaka Fujita; Shinya Sakata; Fumihiko Hirai; Gouji Toyokawa; Eiji Iwama; Taishi Harada; Takashi Seto; Mitsuhiro Takenoyama; Takeshi Ozeki; Taisei Mushiroda; Mieko Inada; Junji Kishimoto; Kenji Tsuchihashi; Kentaro Suina; Osamu Nagano; Hideyuki Saya; Yoichi Nakanishi; Isamu Okamoto
Journal:  Cancer Sci       Date:  2017-07-26       Impact factor: 6.716

Review 10.  Drug resistance related to aberrant glycosylation in colorectal cancer.

Authors:  Ninon Very; Tony Lefebvre; Ikram El Yazidi-Belkoura
Journal:  Oncotarget       Date:  2017-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.